SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-013927
Filing Date
2021-11-01
Accepted
2021-11-01 17:01:00
Documents
12
Period of Report
2021-10-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20211026x8k.htm   iXBRL 8-K 32935
  Complete submission text file 0001558370-21-013927.txt   157141

Data Files

Seq Description Document Type Size
2 EX-101.SCH tmb-20211026.xsd EX-101.SCH 3038
3 EX-101.LAB tmb-20211026_lab.xml EX-101.LAB 16735
4 EX-101.PRE tmb-20211026_pre.xml EX-101.PRE 10614
5 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20211026x8k_htm.xml XML 5113
Mailing Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103
Business Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Filer) CIK: 0001787297 (see all company filings)

IRS No.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39231 | Film No.: 211368014
SIC: 2836 Biological Products, (No Diagnostic Substances)